vs

Side-by-side financial comparison of Spectral AI, Inc. (MDAI) and Xos, Inc. (XOS). Click either name above to swap in a different company.

Xos, Inc. is the larger business by last-quarter revenue ($5.2M vs $4.1M, roughly 1.3× Spectral AI, Inc.). Spectral AI, Inc. runs the higher net margin — 25.7% vs -186.8%, a 212.6% gap on every dollar of revenue. On growth, Spectral AI, Inc. posted the faster year-over-year revenue change (-46.3% vs -54.5%). Over the past eight quarters, Spectral AI, Inc.'s revenue compounded faster (-19.6% CAGR vs -35.7%).

Spectral AI, Inc. is a medical technology firm specializing in AI-powered diagnostic imaging solutions primarily for burn and wound care. It develops non-invasive imaging tools that enable healthcare providers to deliver faster, more accurate treatment assessments, serving clinical and healthcare partner networks across North America and European markets.

Xos, Inc. is an American manufacturer of commercial electric vehicles (EVs) and mobile EV chargers.

MDAI vs XOS — Head-to-Head

Bigger by revenue
XOS
XOS
1.3× larger
XOS
$5.2M
$4.1M
MDAI
Growing faster (revenue YoY)
MDAI
MDAI
+8.2% gap
MDAI
-46.3%
-54.5%
XOS
Higher net margin
MDAI
MDAI
212.6% more per $
MDAI
25.7%
-186.8%
XOS
Faster 2-yr revenue CAGR
MDAI
MDAI
Annualised
MDAI
-19.6%
-35.7%
XOS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDAI
MDAI
XOS
XOS
Revenue
$4.1M
$5.2M
Net Profit
$1.1M
$-9.8M
Gross Margin
45.2%
-50.5%
Operating Margin
-54.9%
-186.6%
Net Margin
25.7%
-186.8%
Revenue YoY
-46.3%
-54.5%
Net Profit YoY
113.9%
48.6%
EPS (diluted)
$0.04
$-0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDAI
MDAI
XOS
XOS
Q4 25
$4.1M
$5.2M
Q3 25
$3.8M
$16.5M
Q2 25
$5.1M
$18.4M
Q1 25
$6.7M
$5.9M
Q4 24
$7.6M
$11.5M
Q3 24
$8.2M
$15.8M
Q2 24
$7.5M
$15.5M
Q1 24
$6.3M
$12.6M
Net Profit
MDAI
MDAI
XOS
XOS
Q4 25
$1.1M
$-9.8M
Q3 25
$-3.6M
$2.1M
Q2 25
$-8.0M
$-7.5M
Q1 25
$2.9M
$-10.2M
Q4 24
$-7.6M
$-19.0M
Q3 24
$-1.5M
$-10.5M
Q2 24
$-2.9M
$-9.7M
Q1 24
$-3.2M
$-11.0M
Gross Margin
MDAI
MDAI
XOS
XOS
Q4 25
45.2%
-50.5%
Q3 25
42.7%
15.3%
Q2 25
45.2%
8.8%
Q1 25
47.2%
20.6%
Q4 24
44.0%
-32.4%
Q3 24
44.9%
18.1%
Q2 24
44.3%
13.1%
Q1 24
46.6%
22.1%
Operating Margin
MDAI
MDAI
XOS
XOS
Q4 25
-54.9%
-186.6%
Q3 25
-88.1%
-42.4%
Q2 25
-41.9%
-38.5%
Q1 25
-13.4%
-157.7%
Q4 24
-14.6%
-127.0%
Q3 24
-10.8%
-61.4%
Q2 24
-32.7%
-73.2%
Q1 24
-33.9%
-81.1%
Net Margin
MDAI
MDAI
XOS
XOS
Q4 25
25.7%
-186.8%
Q3 25
-93.7%
12.9%
Q2 25
-157.3%
-40.8%
Q1 25
43.2%
-173.3%
Q4 24
-99.8%
-165.4%
Q3 24
-18.4%
-66.6%
Q2 24
-38.3%
-62.2%
Q1 24
-50.7%
-87.1%
EPS (diluted)
MDAI
MDAI
XOS
XOS
Q4 25
$0.04
$-0.76
Q3 25
$-0.13
$0.22
Q2 25
$-0.31
$-0.91
Q1 25
$0.11
$-1.26
Q4 24
$-0.42
$-2.34
Q3 24
$-0.08
$-1.32
Q2 24
$-0.16
$-1.23
Q1 24
$-0.19
$-1.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDAI
MDAI
XOS
XOS
Cash + ST InvestmentsLiquidity on hand
$15.4M
$14.0M
Total DebtLower is stronger
$9.3M
Stockholders' EquityBook value
$-5.7M
$23.3M
Total Assets
$21.4M
$60.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDAI
MDAI
XOS
XOS
Q4 25
$15.4M
$14.0M
Q3 25
$10.5M
$14.1M
Q2 25
$10.5M
$8.8M
Q1 25
$14.1M
$4.8M
Q4 24
$5.2M
$11.0M
Q3 24
$3.7M
$8.4M
Q2 24
$6.9M
$19.7M
Q1 24
$10.2M
$46.2M
Total Debt
MDAI
MDAI
XOS
XOS
Q4 25
$9.3M
Q3 25
Q2 25
Q1 25
$7.8M
Q4 24
$2.8M
Q3 24
$1.0M
Q2 24
Q1 24
Stockholders' Equity
MDAI
MDAI
XOS
XOS
Q4 25
$-5.7M
$23.3M
Q3 25
$-8.2M
$31.1M
Q2 25
$-9.2M
$18.3M
Q1 25
$-1.6M
$24.8M
Q4 24
$-7.3M
$33.6M
Q3 24
$-4.8M
$50.8M
Q2 24
$-4.7M
$59.2M
Q1 24
$-2.5M
$67.8M
Total Assets
MDAI
MDAI
XOS
XOS
Q4 25
$21.4M
$60.4M
Q3 25
$15.3M
$73.8M
Q2 25
$16.0M
$80.3M
Q1 25
$20.7M
$87.7M
Q4 24
$12.1M
$98.3M
Q3 24
$11.6M
$120.5M
Q2 24
$13.9M
$123.4M
Q1 24
$15.5M
$135.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDAI
MDAI
XOS
XOS
Operating Cash FlowLast quarter
$-2.6M
$2.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-2.43×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDAI
MDAI
XOS
XOS
Q4 25
$-2.6M
$2.4M
Q3 25
$-2.5M
$3.1M
Q2 25
$-3.4M
$4.6M
Q1 25
$-1.5M
$-4.8M
Q4 24
$469.0K
$3.3M
Q3 24
$-1.6M
$-11.5M
Q2 24
$-5.4M
$-26.0M
Q1 24
$-2.7M
$-14.6M
Free Cash Flow
MDAI
MDAI
XOS
XOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-11.7M
Q2 24
$-26.1M
Q1 24
$-14.6M
FCF Margin
MDAI
MDAI
XOS
XOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-73.9%
Q2 24
-168.1%
Q1 24
-115.7%
Capex Intensity
MDAI
MDAI
XOS
XOS
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.9%
Q2 24
0.8%
Q1 24
0.2%
Cash Conversion
MDAI
MDAI
XOS
XOS
Q4 25
-2.43×
Q3 25
1.45×
Q2 25
Q1 25
-0.52×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons